Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Development Center for Biotechnology (DCB) is a government-supported non-profit research organization in Taiwan dedicated to the growth of the domestic biotechnology industry. It serves as a bridge between academic research and industrial commercialization, focusing on the development of biologics, small molecule drugs, and advanced therapies. DCB provides a wide range of services including preclinical testing, technology transfer, and business incubation. The center is particularly noted for its proprietary antibody-drug conjugate (ADC) platforms and its role in fostering international collaborations within the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technology Transfer Consortium Biotechnology Development Center.